Ignite Creation Date:
2025-12-24 @ 11:43 PM
Ignite Modification Date:
2025-12-25 @ 9:36 PM
Study NCT ID:
NCT04790851
Status:
COMPLETED
Last Update Posted:
2021-10-20
First Post:
2021-03-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4
Sponsor:
China National Biotec Group Company Limited
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-10
Start Date Type:
ACTUAL
Primary Completion Date:
2021-09-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-09-05
Completion Date Type:
ACTUAL
First Submit Date:
2021-03-08
First Submit QC Date:
None
Study First Post Date:
2021-03-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-12
Last Update Post Date:
2021-10-20
Last Update Post Date Type:
ACTUAL